US Broker Ratings

Elanco Animal Health (ELAN) Stock Analysis: Evaluating Its Market Position and Potential Upside

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, is an innovative force in the niche of animal health. The company’s extensive portfolio caters to both..

Baxter International Inc. (BAX) Stock Analysis: Uncovering a 33.6% Upside Potential in the Healthcare Sector

Baxter International Inc. (NYSE: BAX), a notable player in the healthcare sector, continues to capture investor attention with a compelling opportunity for upside. As the company navigates a complex landscape..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A Biotech with 38.72% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leader in the biotechnology sector, is gaining interest among investors for its promising RNA-targeted medicines and potential upside of 38.72%. With a current market..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 25% Potential Upside in the Healthcare Sector

As Grifols, S.A. (NASDAQ: GRFS) navigates the dynamic landscape of healthcare, individual investors are eyeing its stock with increasing interest due to its promising potential upside of 25.10%. This Spanish..

UnitedHealth Group (UNH) Stock Analysis: A Compelling 26.69% Upside for Investors

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, represents a pivotal player in the healthcare plans industry. With a market capitalization of $275.86 billion, UNH is a..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unveiling a 28.32% Upside in the Biotech Sector

In the dynamic world of biotechnology, BridgeBio Pharma, Inc. (NASDAQ: BBIO) stands out as a promising yet complex player. With an impressive market capitalization of $8.82 billion, this Palo Alto-based..

Nuvalent, Inc. (NUVL) Stock Analysis: Strong Buy Ratings and 44.94% Potential Upside Captivate Investors

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, is quickly becoming a focal point for investors within the healthcare sector. With a market capitalization of $5.81 billion, Nuvalent is not..

ICON plc (ICLR) Investor Outlook: Analyst Consensus Suggests a 16.4% Upside Potential

ICON plc (NASDAQ: ICLR) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. This Ireland-based clinical research organization is renowned for providing outsourced..

Tempus AI, Inc. (TEM) Investor Outlook: Analyzing the 17.26% Upside Potential

Tempus AI, Inc. (NASDAQ: TEM), a leader in healthcare technology, presents a compelling investment opportunity with a potential upside of 17.26%, according to current analyst ratings. The company, which resides..

McKesson Corporation (MCK): Investor Outlook Highlights Growth Potential and Analyst Consensus

McKesson Corporation (NYSE: MCK) is a formidable presence in the healthcare sector, specifically within the medical distribution industry. With a market capitalization of $88.63 billion, McKesson is a key player..

ResMed Inc. (RMD) Stock Analysis: A Healthcare Titan with a 3.97% Potential Upside

For investors with a keen eye on the healthcare sector, ResMed Inc. (NYSE: RMD) presents an intriguing opportunity. With a market capitalization of $37.3 billion, this San Diego-based giant occupies..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 49.1% Potential Upside Amidst Healthcare Innovations

Investors looking for opportunities in the healthcare sector might find Globus Medical, Inc. (NYSE: GMED) an intriguing option. With a market capitalization of $7.73 billion, Globus Medical is a prominent..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Why Analysts Predict a 34% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) stands at an intriguing juncture for investors, particularly those drawn to the high-risk, high-reward nature of the biotechnology sector. With a current market capitalization of..

Regencell Bioscience Holdings (RGC): Growth Potential and Market Dynamics for the Hong Kong-Based TCM Innovator

Regencell Bioscience Holdings Limited (NASDAQ: RGC) presents a unique profile within the healthcare sector as a Hong Kong-based company focused on Traditional Chinese Medicine (TCM). Specializing in the development of..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A 91.77% Potential Upside in Biotech Innovation

Investors with an eye on the biotechnology sector might find Revolution Medicines, Inc. (NASDAQ: RVMD) an enticing opportunity. This clinical-stage precision oncology company, headquartered in Redwood City, California, is making..

Charles River Laboratories (CRL) Stock Analysis: A Healthcare Giant with Growth Potential Amidst Recent Challenges

Charles River Laboratories International, Inc. (CRL), a notable player in the Healthcare sector’s Diagnostics & Research industry, continues to be a focal point for investors seeking robust opportunities in the..

HealthEquity, Inc. (HQY) Stock Analysis: Strong Buy Ratings Signal a Promising 28.77% Upside

HealthEquity, Inc. (NASDAQ: HQY) is capturing attention in the healthcare sector as a leading player in health information services. Based in Draper, Utah, the company offers a suite of technology-enabled..

Stevanato Group S.p.A. (STVN) Stock Analysis: A Promising 13.50% Upside Amidst Healthcare Innovations

Investors seeking opportunities in the healthcare sector should turn their attention to Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the medical instruments and supplies industry. With a market..

Chemed Corp (CHE) Stock Analysis: Exploring a 40% Upside Potential with Robust Financials

Chemed Corporation (NYSE: CHE) stands as a notable player within the healthcare sector, specifically in the medical care facilities industry. With its unique dual operations—offering hospice and palliative care through..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 24% Potential Upside in the Biotech Sector

Bio-Techne Corporation (NASDAQ: TECH) stands as a prominent player in the biotechnology sector, presenting an intriguing investment opportunity for those interested in the healthcare industry. With a market capitalization of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds